T
Trudy L. Bush
Researcher at Johns Hopkins University
Publications - 47
Citations - 12449
Trudy L. Bush is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 30, co-authored 47 publications receiving 12158 citations. Previous affiliations of Trudy L. Bush include Oklahoma Medical Research Foundation & University of Maryland, Baltimore.
Papers
More filters
Journal Article
Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer
TL;DR: In this paper, they measured serum levels of these steroids in 30 postmenopausal women who donated blood in 1974 for a community-based serum bank and who subsequently, at least 9 years later, developed breast cancer and in 59 matched controls from the same group of volunteers.
Journal ArticleDOI
Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial
Robert Marcus,Gail A. Greendale,Barbara A. Blunt,Trudy L. Bush,Sherry Sherman,Roger Sherwin,Heinz W. Wahner,Bradley Wells +7 more
TL;DR: It is concluded that increased body mass is positively correlated with BMD, and this may confer a degree of skeletal protection to heavier postmenopausal women.
Journal ArticleDOI
Does Comorbid Disease Interact With Cancer? An Epidemiologic Analysis of Mortality in a Cohort of Elderly Breast Cancer Patients
Craig J. Newschaffer,Craig J. Newschaffer,Trudy L. Bush,Trudy L. Bush,Lynne E. Penberthy,Michelle Bellantoni,Kathy Helzlsour,Marie Diener-West +7 more
TL;DR: This study provides the first empirical estimates of statistical interaction between breast cancer and other chronic comorbidity and revealed a pattern of S estimates across cancer stage subgroups that was biologically sensible, but this pattern was not supported by strong statistical evidence.
Journal ArticleDOI
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Virginia L. Ernster,Trudy L. Bush,George R. Huggins,Barbara S. Hulka,Jennifer L. Kelsey,David Schottenfeld +5 more
TL;DR: It is concluded that estrogen replacement therapy is of potential benefit to postmenopausal women, but that the question of progestin supplementation requires further study, particularly for CAD risk.
Journal ArticleDOI
Prospective study of serum CA-125 levels as markers of ovarian cancer
Kathy J. Helzlsouer,Trudy L. Bush,Anthony J. Alberg,Katherine Miller Bass,Howard A. Zacur,George W. Comstock +5 more
TL;DR: Measurement of serum CA-125 levels, particularly at a reference value of 35 U/mL, is not sufficiently sensitive to be used alone as a screening test for the detection of ovarian cancer, and cannot be recommended for this purpose.